Empresa Aequus Pharmaceuticals Inc Toronto S.E.
Acciones
CA0076361033
Farmacéuticos
Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100,0
%
| 0 | 17,6 % | 0 | 100,0 % | +5,01 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -81,53 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 01/01/13 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 22/07/16 |
Andre Mbeng
AUD | Comptroller/Controller/Auditor | 45 | 01/11/20 |
Grant Larsen
PRN | Corporate Officer/Principal | - | 17/08/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Marc Lustig
BRD | Director/Board Member | 51 | 15/02/21 |
Director/Board Member | 54 | 18/12/14 | |
Anne Stevens
FOU | Founder | - | 01/01/13 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 132 634 431 | 113 163 965 ( 85,32 %) | 0 | 85,32 % |
Información de la empresa
Aequus Pharmaceuticals, Inc.
200 Granville Street Suite 2820
V6C 1S4, Vancouver
+604 336 7906
http://www.aequuspharma.caVentas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,78 % | 723 mil M | |
+31,41 % | 598 mil M | |
-3,51 % | 364 mil M | |
+19,94 % | 331 mil M | |
+5,14 % | 288 mil M | |
+16,57 % | 244 mil M | |
-4,58 % | 208 mil M | |
+9,93 % | 210 mil M | |
+9,32 % | 169 mil M |